These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Laboratory-developed tests are not the practice of medicine. Allen JS MLO Med Lab Obs; 2015 Sep; 47(9):46. PubMed ID: 26495599 [No Abstract] [Full Text] [Related]
5. Improving clinical laboratory performance through quality indicators. Krintus M; Plebani M; Panteghini M Clin Biochem; 2017 Jul; 50(10-11):547-549. PubMed ID: 28499800 [No Abstract] [Full Text] [Related]
6. FDA oversight of laboratory-developed tests will facilitate adoption of pharmacogenetic testing into routine clinical care. Hillebrenner E; Litwack E; Bradley P; Donigan K; Lowe T; Serrano K; Kelm K; Mansfield E; Gutierrez A J Clin Pharmacol; 2015 Jul; 55(7):728-30. PubMed ID: 26053648 [No Abstract] [Full Text] [Related]
7. US Food and Drug Administration regulatory oversight of laboratory-developed tests: Commentary on the draft guidance. Sidawy MK Cancer Cytopathol; 2015 Oct; 123(10):573-5. PubMed ID: 26042383 [No Abstract] [Full Text] [Related]
8. Recommended practices for the management of embryology, andrology, and endocrinology laboratories: a committee opinion. ; ; Fertil Steril; 2014 Oct; 102(4):960-3. PubMed ID: 25064400 [TBL] [Abstract][Full Text] [Related]
9. New coding tool for clinical pharmacology. Westin AA; Bjånes TK Tidsskr Nor Laegeforen; 2015 Sep; 135(17):1537-8. PubMed ID: 26394582 [No Abstract] [Full Text] [Related]
10. The Norwegian Laboratory Coding System - what became of the visions? Westin AA; Wester AL; Stray-Pedersen A; Løhne K; Chen Y; Olaussen RW Tidsskr Nor Laegeforen; 2016 Sep; 136(16):1370-2. PubMed ID: 27637058 [No Abstract] [Full Text] [Related]
11. Decreasing inappropriate laboratory test utilization: controlling costs and improving quality of care. Wilson ML Am J Clin Pathol; 2015 May; 143(5):614-6. PubMed ID: 25873491 [No Abstract] [Full Text] [Related]
12. FDA's draft guidance on laboratory-developed tests increases clinical and economic risk to adoption of pharmacogenetic testing. Levy KD; Pratt VM; Skaar TC; Vance GH; Flockhart DA J Clin Pharmacol; 2015 Jul; 55(7):725-7. PubMed ID: 26053647 [No Abstract] [Full Text] [Related]
13. On-line flagging monitoring - a new quality management tool for the analytical phase. Goossens K; Brinkmann T; Thienpont LM Clin Chem Lab Med; 2015 Sep; 53(10):e269-70. PubMed ID: 25898395 [No Abstract] [Full Text] [Related]
14. Once upon a time: a tale of ISO 15189 accreditation. Plebani M; Sciacovelli L; Chiozza ML; Panteghini M Clin Chem Lab Med; 2015 Jul; 53(8):1127-9. PubMed ID: 25992514 [No Abstract] [Full Text] [Related]
16. [The concept of reference change values (RCV). Will it supersede reference intervals?]. Walz B; Fierz W Ther Umsch; 2015 Feb; 72(2):130-5. PubMed ID: 25630296 [TBL] [Abstract][Full Text] [Related]
17. [Update to ISO 15189:2012, and future prospects]. Shimoda K; Kubono K Rinsho Byori; 2014 Jun; 62(6):620-3. PubMed ID: 25151783 [TBL] [Abstract][Full Text] [Related]
18. Facing the Inevitable: Being Prepared for Regulatory Requirements for Laboratory Developed Tests. D'Angelo R; Weiss R; Wolfe D; Chinnam R; Murat A; Gluesing J; Somers T Am J Clin Pathol; 2018 Apr; 149(6):484-498. PubMed ID: 29659675 [TBL] [Abstract][Full Text] [Related]
19. [Guidelines for the pre-examination processing and transport of medical laboratory samples]. Annette-Reisch M; Soubiran P; Szymanowicz A; Ann Biol Clin (Paris); 2010 Dec; 68 Spec No 1():111-29. PubMed ID: 21613010 [TBL] [Abstract][Full Text] [Related]
20. [Guidelines for the order process of medical laboratory tests]. Annaix V; Drouillard I; Palette X; Serre-Debeauvais F; Szymanowicz A; Yvert JP; Ann Biol Clin (Paris); 2010 Dec; 68 Spec No 1():43-67. PubMed ID: 21613007 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]